X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11803) 11803
Book Review (1774) 1774
Publication (690) 690
Newsletter (70) 70
Book Chapter (34) 34
Magazine Article (26) 26
Conference Proceeding (15) 15
Book / eBook (9) 9
Dissertation (7) 7
Newspaper Article (5) 5
Government Document (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10338) 10338
humans (9350) 9350
male (4998) 4998
female (4467) 4467
adult (3233) 3233
pseudomonas aeruginosa (3139) 3139
middle aged (2543) 2543
pseudomonas infections - complications (2500) 2500
cystic fibrosis - complications (2266) 2266
pseudomonas infections - drug therapy (2181) 2181
pseudomonas-aeruginosa (2074) 2074
anti-bacterial agents - therapeutic use (1880) 1880
pseudomonas aeruginosa - isolation & purification (1838) 1838
aged (1834) 1834
adolescent (1830) 1830
cystic fibrosis (1829) 1829
abridged index medicus (1801) 1801
microbiology (1795) 1795
animals (1748) 1748
child (1743) 1743
pseudomonas infections - microbiology (1572) 1572
infectious diseases (1511) 1511
infections (1442) 1442
pseudomonas infections - etiology (1379) 1379
infection (1219) 1219
antibiotics (1182) 1182
respiratory system (1173) 1173
bacteria (1172) 1172
pseudomonas aeruginosa - drug effects (1109) 1109
health aspects (1074) 1074
child, preschool (1052) 1052
risk factors (1037) 1037
cystic fibrosis - microbiology (901) 901
surgery (860) 860
infant (856) 856
retrospective studies (846) 846
research (839) 839
anti-bacterial agents - pharmacology (823) 823
microbial sensitivity tests (817) 817
immunology (786) 786
mice (780) 780
pseudomonas infections - diagnosis (767) 767
treatment outcome (750) 750
pediatrics (738) 738
anti-bacterial agents - administration & dosage (704) 704
care and treatment (648) 648
pharmacology & pharmacy (646) 646
mortality (636) 636
analysis (624) 624
burns - complications (620) 620
pseudomonas (602) 602
pseudomonas infections (582) 582
pneumonia (565) 565
children (557) 557
medicine, general & internal (557) 557
chronic disease (549) 549
young adult (539) 539
time factors (533) 533
aged, 80 and over (529) 529
biofilms (528) 528
pseudomonas infections - epidemiology (522) 522
diagnosis (504) 504
epidemiology (490) 490
inflammation (484) 484
cystic-fibrosis (475) 475
pseudomonas infections - prevention & control (475) 475
prospective studies (473) 473
pseudomonas aeruginosa - genetics (470) 470
pseudomonas aeruginosa - pathogenicity (468) 468
pathogens (461) 461
pseudomonas infections - immunology (460) 460
sputum - microbiology (452) 452
bacterial infections (448) 448
research article (444) 444
colonization (442) 442
disease models, animal (436) 436
complications and side effects (432) 432
virulence (428) 428
therapy (410) 410
risk-factors (406) 406
bacteremia (405) 405
infant, newborn (403) 403
drug resistance in microorganisms (402) 402
pseudomonas infections - therapy (402) 402
resistance (395) 395
drug resistance (390) 390
pseudomonas aeruginosa - physiology (388) 388
medicine (386) 386
sepsis (383) 383
pseudomonas aeruginosa - immunology (378) 378
staphylococcus-aureus (375) 375
critical care medicine (370) 370
drug therapy, combination (368) 368
patients (366) 366
pseudomonas infections - pathology (363) 363
complications (359) 359
nosocomial infections (356) 356
disease (352) 352
ophthalmology (347) 347
escherichia-coli (345) 345
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10706) 10706
French (261) 261
Spanish (204) 204
German (185) 185
Russian (182) 182
Japanese (119) 119
Italian (67) 67
Polish (62) 62
Chinese (49) 49
Turkish (14) 14
Czech (11) 11
Romanian (11) 11
Dutch (10) 10
Portuguese (10) 10
Danish (7) 7
Hungarian (7) 7
Hebrew (6) 6
Korean (6) 6
Slovak (5) 5
Serbian (4) 4
Finnish (3) 3
Persian (3) 3
Swedish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Indonesian (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37281 - e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Index Medicus | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 07/2011, Volume 184, Issue 1, pp. 75 - 81
Journal Article
Chest, ISSN 0012-3692, 2017, Volume 151, Issue 5, pp. 1011 - 1017
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 08/2015, Volume 45, Issue 8, pp. 824 - 832
BackgroundCatheter-related bloodstream infections (CRBSIs) are currently detected in patients with clinically suspicion. The aim of our study was to evaluate... 
haematooncology | screening | catheter‐related blood stream infection | peptide nucleic acid fluorescence in situ hybridization | Acridine orange leucocyte cytospin | Peptide nucleic acid fluorescence in situ hybridization | Screening | Catheter-related blood stream infection | Haematooncology | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | MANAGEMENT | GUIDELINES | PREVENTION | SOCIETY | MEDICINE, GENERAL & INTERNAL | ONCOLOGY | peptide nucleic acid fluorescence insitu hybridization | BACTEREMIA | POSITIVITY | HEMATOLOGY | catheter-related blood stream infection | CULTURES | Enterobacteriaceae Infections - diagnosis | Fungemia - complications | Humans | Middle Aged | Male | Staphylococcal Infections - complications | Candidiasis - diagnosis | Enterobacteriaceae Infections - complications | Peptide Nucleic Acids | Adult | Female | Catheter-Related Infections - diagnosis | Hematologic Neoplasms - complications | Gram-Positive Bacterial Infections - complications | Stenotrophomonas maltophilia | Escherichia coli Infections - diagnosis | Central Venous Catheters | Bacteremia - complications | False Negative Reactions | Gram-Negative Bacterial Infections - complications | Pseudomonas Infections - complications | In Situ Hybridization, Fluorescence | Pseudomonas Infections - diagnosis | Bacteremia - diagnosis | Gram-Positive Bacterial Infections - diagnosis | Klebsiella Infections - complications | Fungemia - diagnosis | Candidiasis - complications | Staphylococcal Infections - diagnosis | Acridine Orange | Klebsiella Infections - diagnosis | Aged | Gram-Negative Bacterial Infections - diagnosis | Catheter-Related Infections - complications | Escherichia coli Infections - complications | Fluorescent Dyes | Cohort Studies | Index Medicus
Journal Article
Otology & Neurotology, ISSN 1531-7129, 09/2015, Volume 36, Issue 9, pp. 1492 - 1498
OBJECTIVES:1) Stratify malignant otitis externa into severe and nonsevere disease categories. 2) Predict treatment courses and outcomes based on this... 
Osteomyelitis | Malignant otitis externa | Skull base | Diabetes | Pseudomonas | Stratification | Outcomes | DIAGNOSIS | INVOLVEMENT | FOLLOW-UP | PATTERNS | SKULL-BASE OSTEOMYELITIS | CLINICAL NEUROLOGY | OTORHINOLARYNGOLOGY | ANTIBIOTIC-TREATMENT | Aspergillosis - therapy | Diabetes Complications - classification | Recurrence | Staphylococcal Infections - classification | Aspergillosis - diagnostic imaging | Humans | Middle Aged | Otitis Externa - complications | Male | Tomography, X-Ray Computed | Diabetes Complications - therapy | Osteomyelitis - complications | Staphylococcal Infections - complications | Methicillin-Resistant Staphylococcus aureus | Anti-Bacterial Agents - therapeutic use | Facial Nerve Diseases - etiology | Osteomyelitis - therapy | Escherichia coli Infections - therapy | Osteomyelitis - diagnostic imaging | Otitis Externa - diagnostic imaging | Aged, 80 and over | Adult | Female | Diabetes Complications - diagnostic imaging | Retrospective Studies | Aspergillosis - classification | Aspergillosis - complications | Escherichia coli Infections - diagnostic imaging | Osteomyelitis - classification | Severity of Illness Index | Otitis Externa - classification | Pseudomonas Infections - therapy | Pseudomonas Infections - complications | Treatment Outcome | Hospitalization | Otitis Externa - therapy | Pseudomonas Infections - diagnostic imaging | Diabetes Mellitus | Pseudomonas Infections - classification | Staphylococcal Infections - diagnostic imaging | Disease Progression | Staphylococcal Infections - therapy | Debridement | Aged | Escherichia coli Infections - classification | Chronic Disease | Escherichia coli Infections - complications | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2006, Volume 103, Issue 22, pp. 8487 - 8492
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE... 
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | INFECTIOUS DISEASES | INITIAL ANTIBIOTIC-THERAPY | ANTIMICROBIAL THERAPY | MICROBIOLOGY | IMMUNOLOGY | INTRAABDOMINAL INFECTION | CARBAPENEM-RESISTANT ENTEROBACTERIACEAE | TREATMENT OPTIONS | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | KLEBSIELLA-PNEUMONIAE | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | Index Medicus | and Commentaries
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 135, Issue 6, pp. 1648 - 1651.e5
  MCs appear to play an important role in promoting innate immunity against microbial pathogens.8 Through activation of CD8+ T cells, MCs possess the ability... 
Allergy and Immunology | IMMUNOLOGY | ALLERGY | BIOFILMS | CHRONIC RHINOSINUSITIS | Prospective Studies | Staphylococcal Infections - pathology | Staphylococcus aureus - physiology | Humans | Biofilms - growth & development | Pseudomonas aeruginosa - physiology | Staphylococcal Infections - complications | Haemophilus Infections - complications | Case-Control Studies | Mast Cells - microbiology | Sinusitis - complications | Nasal Polyps - microbiology | Rhinitis - microbiology | Sinusitis - immunology | Sinusitis - microbiology | Sinusitis - pathology | Staphylococcal Infections - microbiology | Haemophilus Infections - pathology | Mast Cells - immunology | Nasal Polyps - immunology | Rhinitis - immunology | Nasal Polyps - pathology | Staphylococcal Infections - immunology | Pseudomonas Infections - complications | Pseudomonas Infections - microbiology | Pseudomonas Infections - immunology | Nasal Polyps - complications | Mast Cells - pathology | Haemophilus Infections - microbiology | Haemophilus influenzae - physiology | Pseudomonas Infections - pathology | Rhinitis - complications | Haemophilus Infections - immunology | Rhinitis - pathology | Chronic Disease | Staphylococcus aureus | Tribology | Studies | Biofilms | Bacteria | Antimicrobial agents | Hybridization | Patients | Bacteriology | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article